Check-Cap (MBAI) Stock Price, News & Analysis

Company Overview

Check-Cap Ltd. (NASDAQ: MBAI) is an Israel-based medical technology company focused on non-invasive screening solutions for colorectal cancer. The company develops an ingestible imaging capsule and associated detection system intended to provide a patient-friendly alternative to traditional colonoscopy and CT colonography for colorectal screening and polyp detection.

Check-Cap’s technology centers on a swallowable capsule that acquires images of the colon as it traverses the gastrointestinal tract; external detectors capture the transmitted signals and software reconstructs images for clinical review. The system is designed to use low-dose X-ray imaging and to reduce the need for extensive bowel preparation compared with standard colonoscopy, aiming to improve patient comfort and screening compliance. The company’s product development has emphasized portability, safety and integration of image-processing tools to support clinician interpretation.

Check-Cap has conducted clinical studies to evaluate the performance and safety of its capsule-based system and has engaged with regulatory authorities as part of its development pathway. Headquartered in Israel and listed on the Nasdaq under the ticker MBAI, the company is positioned in the medical device sector as it seeks regulatory clearance and broader clinical adoption; specific commercial availability and regulatory status should be confirmed from the company’s public filings and announcements. I couldn't find enough reliable, current information to provide named leadership or definitive commercialization status without risk of inaccuracy.

Key Stats

• Today's Range: $0.95 to $1.00
• 50-Day Range: $0.95 to $2.00
• 52-Week Range: $0.59 to $3.92
• Volume: 15,369 shs
• Average Volume: 71,971 shs
• Market Capitalization: $6.93 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Check-Cap Stock Analysis - MarketRank™

Check-Cap scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Check-Cap has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Check-Cap has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Check-Cap is -0.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Check-Cap is -0.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Check-Cap has a P/B Ratio of 2.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.21% of the float of Check-Cap has been sold short.

Short Interest Ratio / Days to Cover

Check-Cap has a short interest ratio ("days to cover") of 1.01, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Check-Cap has recently decreased by 31.18%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Check-Cap does not currently pay a dividend.

Dividend Growth

Check-Cap does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 3 news articles for Check-Cap this week, compared to 2 articles on an average week.

MarketBeat Follows

Only 1 people have added Check-Cap to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Check-Cap insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.48% of the stock of Check-Cap is held by insiders.

Percentage Held by Institutions

1.07% of the stock of Check-Cap is held by institutions.

Company Calendar

• Today: 7/21/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Surgical, Medical, And Dental Instruments And Supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:MBAI
• CIK: 1610590
• Web: N/A
• Phone: 972-4-8303400
• Fax: 972-4821-1267
• Employees: 80
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.05
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.54 per share
• Price / Cash Flow: 1.76
• Book Value: $0.47 per share
• Price / Book: 2.02

Miscellaneous

• Outstanding Shares: 7,290,000
• Free Float: 7,253,000
• Market Cap: $6.93 million
• Optionable: N/A
• Beta: 0.65